MedPath

A Randomised trial of Adjuvant Chemotherapy (ECF) in Biliary Cancer

Not Applicable
Completed
Conditions
Biliary tract cancer
Cancer
Biliary
Registration Number
ISRCTN18496239
Lead Sponsor
Royal Marsden Hospital (UK)
Brief Summary

1995 results in https://www.ncbi.nlm.nih.gov/pubmed/7488407 (added 26/03/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Histological confirmed carcinoma of biliary tract or gall bladder
2. Disease considered to have been completely resected
3. No metastases on staging

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath